As a follow-up to my Friday, March 4 post regarding Biogen’s MS drug Tysabri, in an “unrelated” event, Biogen announced the resignation of the executive, Thomas J. Bucknum, effective immediately, and gave no reason for the resignation. Bucknum’s sudden departure, comes amid a regulatory inquiry into his sale of Biogen stock the same day the […]
In the same year that the international patent system marked the filing of the one millionth international patent application, a record number of applications, just over 120,000, were filed in 2004 using the Patent Cooperation Treaty (PCT) of the World Intellectual Property Organization (WIPO). Despite reports of the early demise of its research capabilities, the […]
Under Secretary Jon Dudas identified three new United States Patent and Trademark Office (USPTO) initiatives that will speed patent prosecution, and which will save applicants about $30 million annually at a “town-hall meeting” held last Friday in Chicago. Of course, it was a town hall meeting that charged admission but I digress. According to a […]
Just when you thought it was safe to say “FDA”, and things seemed to be calming down ever so slightly with the uproar over COX-2 inhibitors and scrutiny over the FDA approval processes, the issue of suspect drugs plaguing the pharmaceutical industry has now spread to the biotech sector, with one of its best performing […]
Walker Morris in London sent a note regarding the October, 2004, opinion in the patents case Kirin-Amgen v. Hoechst Marion Roussel. The case was the first opportunity for the House to consider the critical question of the extent of protection conferred by a patent under the provisions of the European Patent Convention (EPC), which were […]
The Baristas will be attending the Ohio Valley Affiliates for Life Sciences Group (OVALS) regional conference "The Promise of Innovation: OVALS Making It Happen" on March 7-8, 2005, at the Dayton Marriott Hotel in Dayton, Ohio. Register and see Agenda. The OVALS Partnership developed in 2002 as a forum to discuss and stimulate economic development […]
I was recently reminded about how easy it is to lose patent rights due to a miscalculated publication. Since I regularly represent universities and other research institutions in patent matters, I’m very familiar with publication pressure felt by faculty and students and the inherent rush to be the first to present findings to peers. I […]
Served Up Daily
Editor-in-Chief Barista Stephen Jenei is a patent attorney and Owner of Jenei LLC. When not serving up patent chat over a steaming cup of java, he's handling a diverse intellectual property practice in the biotechnology, pharmaceutical and chemical fields. More info @ Jenei LLC
